Interferon β-1a for optic neuritis patients at high risk for multiple sclerosis
- 1 October 2001
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 132 (4) , 463-471
- https://doi.org/10.1016/s0002-9394(01)01209-0
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-upBrain, 1998
- Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosisAnnals of Neurology, 1998
- Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritisAnnals of Neurology, 1997
- Contrast‐enhanced MR imaging in the evaluation of treatment response and prediction of outcome in multiple sclerosisJournal of Magnetic Resonance Imaging, 1997
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosisBrain, 1993
- Magnetic resonance imaging of the brain in patients with acute monosymptomatic optic neuritisActa Neurologica Scandinavica, 1989
- Disseminated lesions at presentation in patients with optic neuritis.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983